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ABSTRACT 
Objectives: To examine the effect of monotonous driving on a realistic simulator, of sleep 
restriction in OSA patients treated by CPAP, compared with healthy controls.  
Method: In a repeated measure counterbalanced design, 19 CPAP treated, compliant male OSA 
treated patients (OPs) age 50-75y were compared with 20 healthy age-matched controls. All 
participants completed a 2h afternoon, simulated, realistic monotonous drive in an instrumented 
car, following a normal night’s sleep or sleep restricted to 5h (OPs remained on CPAP). Driving 
was monitored for sleepiness-related minor and major lane deviations. EEGs were recorded 
continuously and subjective sleepiness ratings taken frequently.  
Results: After usual sleep there were no between groups differences in driving performance, nor 
in the ability to detect own sleepiness, when groups ‘safely’ drove without major deviation for 
approximately 90min.   However, sleep restriction had a greater effect on OPs, whose ‘safe driving’ 
time was significantly shorter (65min), than the little change for controls. At this point, EEGs in the 
OPs indicated that apart from sleepiness, they were also applying more compensatory effort 
ostensibly to maintain alertness. This might explain their subjective underestimate of this enhanced 
sleepiness. Nevertheless, apart from this caveat, then for the OP group as well as the controls, 
there were generally close associations between subjective sleepiness, likelihood of a major lane 
deviation, and EEG changes indicative of sleepiness.  
Conclusions: With adequate sleep, effectively treated people with OSA appear as safe as control 
drivers, but after shortened sleep and despite realising their sleepiness was greater, albeit still 
similar to controls, this seems to be an underestimate as their driving impairment was much worse 
than that for the controls. 
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INTRODUCTION 
Many patients with obstructive sleep apnoea (OSA) treated by continuous positive airway pressure 
(CPAP) are usually quite fit to drive, as reflected by post-treatment reductions of road traffic 
collisions (1,2), and at similar levels to those of healthy controls(3). Although some OSA treated 
patients (OPs) seem to have residual sleepiness (4,5), this may well be similar to that of healthy 
controls (6). Whilst road accident surveys comparing OPs with controls have equivocal findings, 
they tend not to match for age or annual mileage (7), or assess and compare the seriousness of 
the collisions (2).  
There have been several laboratory-based driving simulator studies ascertaining driving ability in 
OPs. However, simulators vary in realism, from having to follow a simple winding road displayed 
on a standard computer screen and tracked by using a replica steering wheel, to the few advanced 
simulators utilising an instrumented, static real car with a full-size interactive road simulation 
viewed through the windscreen; clearly, the more realistic, the better. Other key variables are the 
time of day of driving and the extent to which the task is monotonous.  Sleep-related collisions are 
most evident early morning and during the afternoon ‘bi-circadian dip’ (8-10), and associated with 
long, unstimulating driving conditions. Although, for example, the UK Department for Transport 
recommends car drivers take breaks from driving every 2h, and the European Union allows truck 
drivers to drive for 4.5h without a break, many of these simulator studies only last around 20-30 
min (eg. 11). Moreover, if a study only provides a minimal practice beforehand, then even the most 
tedious tasks can have initial intrinsic novelty, thus motivating the participant to apply more effort.  
Other studies have taken place during the morning, when alertness is naturally on an incline. Thus, 
under these various experimental conditions it is possible for CPAP treated drivers to display 
normal driving behaviour, when the testing circumstances are inadequate to detect sleepiness 
under more realistic scenarios. Even those studies depending solely on driver reaction times can 
be misleading, as we have shown (12), and where drivers can be unduly distracted by this task 
and fail to anticipate hazards.  Besides, reaction times do not generally ‘slow down’ in sleepy 
drivers, but are either normal or nil (as in a lapse or microsleep).  
Few studies have utilised advanced driving simulators to study post CPAP effectiveness on OPs.   
Using a variety of neuropsychological measures, as well as an advanced simulator, Orth et al (13) 
assessed the effects of CPAP on 31 male OPs.  After a 15min practice, a one hour monotonous 
drive during either mid-morning or late afternoon, towards the circadian daily alertness peak, 
showed significant and marked improvements 42 days after initiation of CPAP, although there was 
no healthy control group.  Driving ability bore no relationship with any of the neuropsychological 
tests, nor with polysomnographic determined sleep parameters, leaving the authors to conclude 
that, “car driving and its simulation is a comprehensive task which cannot be reflected in 
neuropsychological testing investigating specific aspects of attention, one at a time” (p 901)  
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Inasmuch that undiagnosed OSA sufferers usually experience chronic sleepiness, it is feasible 
that any acute addition to their sleepiness (eg. a curtailed night’s sleep) is more likely to be masked 
than in the case of a healthy driver, and with less forewarning of an impending episode of falling 
asleep at the wheel; although, this is a matter that still requires further exploration.  Whilst this may 
no longer apply to compliant OPs effectively treated by CPAP, whose excessive daytime 
sleepiness is largely eliminated (and their usually being permitted to drive), there will be occasions 
of a night’s shortened sleep, maybe for work or family reasons when, like any healthy person, they 
are liable to experience increased sleepiness, particularly early afternoon.  The issue then arises 
as to their ability to detect this transient increase in sleepiness, and whether it is sufficient for safe 
driving.  No driving study has assessed curtailed sleep in treated OPs still maintaining CPAP, and 
this is the focus of the present study. 
More specifically, the main aim of this study is to investigate the impact of modest sleep restriction 
on realistic driving ability in OPs compared with healthy controls and, secondly, to determine their 
state of subjective sleepiness when compared with objective EEG and driving performance 
measures.  This will involve 2h periods of monotonous driving in a real-car interactive simulator, 
including continuous EEG measurement as a further bench-mark for sleepiness (an index seldom 
used in simulator studies), together with on-line subjective assessments of sleepiness.   
METHOD 
Participants 
OPs were recruited from a local sleep apnoea patients association, comprising those diagnosed 
with OSA at the regional sleep clinic, who had received CPAP treatment, were pleased with this, 
and had joined this voluntary support network.  Recruitment was as follows: 170 letters outlining 
the study, containing a preliminary questionnaire (including the Epworth Sleepiness Scale – ESS – 
ref 14), and asking for volunteers, were sent out to men in the association, aged 50-75y. 103 
complied, and an initial screening was undertaken by phone. Seventy had ESS scores <10 (ie. not 
indicative of excessive daytime sleepiness- EDS), of whom 32 were apparently in good health, 
drove >3h per week and lived within 40km of our Centre, and were invited for screening and 
interview.  All were being treated by CPAP and had been attending the clinic annually for check-
ups. The structured interview comprised 39 questions further relating to health and medications 
liable to affect sleep and sleepiness (including CPAP usage), as well as habitual sleep 
characteristics, coffee and alcohol intake. Height, weight and percentage body fat (body 
composition analyzer TBF-300 - Tanita Corporation - Tokyo) were recorded. They also underwent 
a computer based driving hazard perception test, and a 30 min familiarisation drive in the 
simulator. On the basis of this screening, 10 decided not to continue (mostly for reasons of 
inconvenience), and two were asked not to participate as they were not sufficiently proficient at 
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driving the simulator.  This left 20 remaining volunteers (another later withdrew for work reasons, 
leaving 19). All had been on CPAP treatment since their diagnosis, for an average of 7.5y.   
Healthy, age matched male control participants were recruited via advert in local papers and 
‘Rotary Clubs’. Respondents were sent similar letters and questionnaires to those of the patients. 
Interested respondents underwent the preliminary screening by phone.  Their sleep was screened 
for sleep disturbance by actimetry, but full PSGs were not undertaken.  These participants were 
also selected for absence of risk factors associated with OSA:  low BMI, non smokers, bed 
partners reporting infrequent snoring etc. Those with BMIs ≤28 then underwent the identical 
procedures to those for the patient group, and 20 were eventually recruited.  Further details of both 
groups can be seen in Table 1.   
The study met with the full approval of the University’s Ethical Committee. For both experimental 
phases (see below), informed consent was obtained after full explanation of procedures. All 
participants were collected from and returned to home via taxi. All participants were given a small 
cash gift on completion. 
Design & Procedure 
All participants completed two conditions (normal night’s sleep, and sleep restricted to 5h by 
delayed bed-time), in a counterbalanced design, with each condition 1-2 weeks apart. To ensure 
compliance with sleep instructions, participants wore wrist actimeters (Cambridge 
Neurotechnology, UK) for three nights prior to each experimental day, when they also kept daily 
logs of: estimated sleep onset, and morning wakening and rising times.  No alcohol was consumed 
36h prior to each drive, and nil caffeine after 18:00h the evening before.  Participants refrained 
from eating after 10:00h on the morning of the drive, and had consumed only a light breakfast. On 
arrival at the laboratory, at 13:00h, they were given a light lunch of two cheese rolls and a glass of 
water. Actimeters were downloaded to verify that they had complied with the previous night’s sleep 
requirements.  At 13:15h electrodes (see below) were applied and they went to the simulator (see 
below) at 13:50h, and given 10 min to settle into the car. The 2h drive began at 14:00h and lasted 
2h, with the shortened night’s sleep having enhanced the afternoon dip. They were instructed to 
drive in the left hand lane (unless overtaking – in the UK we drive on the left) at a speed 
appropriate for the road and to enable full control of the vehicle. During the drive the investigator 
remained in the room, out of sight, but there was no communication between investigator and 
participant once the drive had begun. 
Apparatus 
Car Simulator – This comprises an immobile car with a full-size, interactive, computer generated 
road projection of a dull monotonous dual carriageway; each having two lanes. The image was 
projected onto a 2.0m x 1.5m screen, located 2.3m from the car windscreen.  The road had a hard 
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shoulder and simulated auditory ‘rumble strips’ (incorporated into white lane markings) either side 
of the carriageway, with long straight sections followed by gradual bends. ‘Crash barriers’ are 
located either side, beyond the rumble strips. Slow moving vehicles are met occasionally, which 
have to be overtaken. Lane drifting is the most common manifestation of sleepy driving, and a car 
wheel touching (or crossing) the left rumble strip or right side lane line was identified as a driving 
‘incident’.  Split-screen video footage of the roadway and driver’s face (filmed by an unobtrusive 
infrared camera) enabled the cause of the incident to be determined.  Those caused by sleepiness 
(e.g. eye closure, eyes rolling upwards or vacant staring ahead) were logged as a ‘sleep-related 
incident’. As a further check for the latter, the electroencephalogram (EEG) and electrooculogram 
(EOG - see below) were examined respectively for alpha/theta intrusions and confirmation of any 
“eye rolling.” Non-sleep related incidents (driver distraction, fidgeting or looking around) were 
excluded. 
Sleep-Related Driving incidents - After scrutinising all incidents to exclude non-sleepiness causes, 
two levels of lane drifting were identified: Minor incident – one or two car wheels touching a lane 
line. Major incident – all four wheels out of the driving lane.   
Subjective Sleepiness – Every 200s during the drive, participants were verbally prompted by the 
computer system to report their subjective sleepiness, and their numerical response was based on 
the 9-point Karolinska Sleepiness Scale (KSS): 1=extremely alert, 2=very alert, 3=alert, 4=rather 
alert, 5=neither alert nor sleepy, 6=some signs of sleepiness, 7=sleepy, no effort to stay awake, 
8=sleepy, some effort to stay awake, 9=very sleepy, great effort to keep awake, fighting sleep.  
The scale was located on the car’s dashboard and continuously visible to the driver. This 
prompting and its response quickly became routine for the driver.   
EEG and EOG - Electrodes were attached for two channels of EEG, with inter-electrode distances 
carefully maintained by using the ‘10-20 EEG montage’  (main channel C3-A1, backup channel C4-
A2).  There were two EOG channels (electrodes 1cm lateral to and below left outer canthus and 
1cm lateral to and above right outer canthus; both referred to the centre of the forehead).  EEGs 
and EOGs were recorded using ‘Embla’ (Flaga Medical, Iceland) and spectrally analysed using 
‘Somnologica’ (Flaga) in 4s epochs.  EEG low and high band-pass filtering at >20Hz and <4Hz 
removed slow eye movements and muscle artefact.  In these circumstances, greater EEG power in 
the alpha (8-11Hz) and theta (4-7Hz) ranges reflect increased sleepiness (15-17). We also 
measured beta EEG (13-20Hz) power as there is good evidence that this positively correlates with 
mental effort (18,19) and, in our case, suggestive of trying to stay awake (20-22).  EEG power in 
the 4-11 Hz (theta+alpha) range was averaged in one minute epochs, as was beta activity.  To 
accommodate for individual differences, and to allow comparisons between conditions, each 
individual’s power in these ranges was standardised for all conditions, by taking the difference 
between each minute’s epoch and the individual’s mean value over the first 30min of baseline 
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data, and dividing this by the standard deviation around the mean of that 30min of data. This can 
mean that when 4-11Hz power is particularly low, values may appear initially to be negative. (23).    
 
Statistical Analyses 
Mixed model, repeated measures analysis of variance (ANOVA) were utilised, with one between-
subject (groups) and two within subject factors: i) Condition – two levels: normal sleep and sleep 
restriction; ii) Duration of  driving – four levels:  0-30 min, 30-60min, 60-90min and 90-120min.   
Huynh-Feldt (ε) adjustments were used if sphericity was not assumed.  Where appropriate square 
root transformations corrected for skewed driving incident raw data. For all measures, data was 
collapsed into 30 minute epochs for statistical analysis  
RESULTS 
Driving Incidents 
Minor Incidents – (Figure 1) - There were significant effects for: between conditions 
[F(1,37)=22.3,p< 0.001,ε = 1], with both groups having more minor incidents following sleep 
restriction; and for duration of drive [F (2.0,75.2)=26.9, p< 0.001, ε=0.68]. There was no significant 
difference between the two groups, nor for any significant interactions. However, there was a trend 
for a greater number of minor incidents in the middle hour of the drive for OPs during sleep 
restriction.  
Major Incidents – (Figure 2) Significant effects were found: between conditions [F(1,37)=20.8, p< 
0.001, ε=1]; and for duration of drive [F (1.7,63)=15.0, p<0.001, ε=0.57]. Of particular importance 
was the significant group by condition interaction [F(1,37)=9.4,p<0.05, ε=1], with OPs more 
impaired by sleep restriction.  
Time to first major incident (safe driving time) - After normal sleep the control group drove for an 
average of 97min (s.e. 8min) and the OPs for 89min (7min).  Following sleep restriction these 
values declined to 91min (9min) and 65min (10min) respectively, resulting in a significant 
difference between conditions [F(1,37)=4.0, p<0.05, ε=1], and a significant group by condition 
interaction [F(1,37)=4.2, p<0.05, ε=1], with the OPs being more affected by the restriction.  
Subjective Sleepiness  
KSS – (Figure 3 - mean changes per 200 sec).  The effect of condition (30min epochs) was 
significant as expected [F(1,37)=19.9, p<0.001, ε=1], as was time [F(1.9,72.1)=70.0, p<0.001, 
ε=0.65]. There were no significant differences between groups, or any  interactions.  
EEG 
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Theta+Alpha Power – There was no significant differences between groups or conditions (30 min 
epochs), but there was a significant time effect [F (1.7, 64.2)=35.0, p<0.001, ε=0.58], as can be 
seen in Figure 4, showing changes with time, plotted per minute. There was a significant group by 
time interaction [F (1.7, 64.2)=4.27, p<0.05, ε=0.58] with OPs having increasingly greater 
theta+alpha power during the last hour under both sleep conditions.        
Beta Power – There was a significant effect with time (30 min epochs) [F (1.8, 65.6)=5.8, p<0.05, 
ε=0.59], but no significant overall effect between conditions or groups. However, there was a 
significant group by time interaction [F (1.8,65.6)=4.9, p<0.05, ε=0.59], with OPs having 
progressively more beta power than the control group, beyond the first 30min.  This can be seen 
clearly in Figure 5 showing data per minute.  More specifically, between minutes 60-65 of sleep 
restriction, and just before the mean onset of the first major incident for OPs (see above), beta 
power was significantly higher than at the same time for controls [t (37)=2.0, p= 0.029 – one tail] 
suggesting that OPs may have been increasing compensatory effort. 
Associations between Measures 
Comparisons between Figures 3 and 4 show that for all conditions there are close associations 
between subjective and objective sleepiness as reflected by the KSS and EEG alpha+theta 
respectively.  When the EEG data are compressed into 200 sec epochs and compared with the 
corresponding KSS values within each of the four conditions, all ‘Pearson’s r’ values are above 0.8, 
and very highly significant (df 34; p<001).  That is, participants seem to have good self-insight into 
their physiological sleepiness as determined by the EEG. However, whilst both groups show 
similar KSS changes within conditions, especially with KSS scores for both groups being similar 
with sleep reduction, it is clear that reduced sleep in OPs impacts on major incidents to a to a far 
greater extent (Fig 2), indicating that they may be more sleepy than they realise, despite what 
might appear to be compensatory effort, as reflected by beta power.  Figure 6 is a composite of 
Figures 2 and 3 (with KSS compressed into 30 min epochs), and clearly illustrates this point 
further. That is, despite the close parallels with KSS scores between the two groups within 
conditions, there is approximately a six-fold increase in major incidences following sleep reduction 
in the OP group.   
DISCUSSION 
Ours was a prolonged drive under monotonous but realistic conditions and at a time of day that, 
together, were designed to eke out potential driver sleepiness monitored by a variety of sensitive 
methods including EEG.  After a normal night’s sleep, driving ability in the OP group was 
comparable to that of the controls; thus adding to the evidence from previous reports of no 
significant difference between the driving performances of CPAP treated OSA participants and 
healthy controls (24-28).   
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Nevertheless, following moderate sleep restriction, at a level likely to be encountered on 
occasions in everyday life by both groups, OPs had significantly more major driving incidents and a 
shorter ‘safe’ driving duration. Although no overall difference was found in subjective sleepiness, 
here, between the groups, EEG activity showed OPs to be physiologically sleepier (greater alpha 
and theta activity) under both normal and restricted sleep conditions in the second half of the drive, 
as was power in the beta range, suggesting they applied more effort to remain alert. The 
combination of these two somewhat antagonistic aspects of the EEG may be responsible for the 
apparent underestimate of subjective sleepiness by this group when their driving was clearly 
becoming impaired under sleep restriction.    
The occurrence of ‘major incidents’ on our simulator does not imply that a collision was imminent, 
but that driving had reached a potentially ‘dangerous level’.  No driver actually collided with a slow 
moving car or hit the ‘crash barriers’ (see ‘apparatus’).  Of course, there was no danger to the 
driver, here, as would be the case under real conditions, and it is possible that both groups would 
have been able to drive more ‘safely’ for longer under real conditions.  However, it remains likely 
that following sleep restriction the OP group would still have been more impaired than normal.   
Why OPs should appear to be more vulnerable to sleep restriction in terms of sleepiness impaired 
driving ability, must remain an open question. However co-morbidities such as obesity or perhaps 
prior sleep fragmentation/hypoxemia may have induced enduring alterations to sleep mechanisms 
within the brain.  Heightened daytime sleepiness, independent of OSA, and as a result of severe 
obesity, has been reported (29) for a group of adults having a mean BMI of 45.  Although our OPs 
were generally obese, their mean BMI was much lower than this, averaging 34.5, whereas the 
controls were within the normal range, averaging 25.5.  Despite BMI being a possible confounding 
factor with our study, when we compared in the OP group, their BMIs with increases in major 
incidents as a result of sleep restriction, there was no significant correlation. 
In conclusion, our findings with a group of CPAP treated OSA patients, free of excessive daytime 
sleepiness and able to drive normally under monotonous conditions are, nevertheless, more 
susceptible to increased sleepiness when sleep is shortened, and they may misperceive the extent 
of this additional sleepiness. Thus, they should be advised accordingly.  
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TABLE LEGEND 
Table 1. Participant characteristics - mean and standard errors OSA group n=19; Control group n 
=20. ESS – Epworth Sleepiness Scale (see Method) 
 OSA Group  Control Group T df p 
AGE (y) 63.8 (1.7) 66.6 (1.3) 1.12 37 0.27 
BMI (m2/kg) 34.5 (1.4) 25.5 (0.4) 5.80 37 <0.001 
% FAT 32.4 (1.2) 23.9 (0.8) 5.62 37 <0.001 
ESS 5.3 (0.7) 4.7 (0.6) 0.15 37 0.88 
USUAL SLEEP  (min by 
actimeter) 
460 (8.1) 468 (10.1) 0.93 37 0.36 
SLEEP baseline (min by 
actimeter)  
462 (8.3) 477 (11.1) 1.09 36 0.29 
SLEEP restricted (min by 
actimeter)  
292 (6.1) 289 (5.9) 0.43 37 0.67 
 
 
FIGURE LEGENDS 
 
Figure 1 Minor incidents - per 30 min. There were significant between-condition effects. 
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Figure 2 Major incidents - per 30 min. Significant effects were found between conditions, for 
duration of drive, and the for group by condition interaction, with OSA patients more impaired by 
sleep restriction.  
 
Figure 3 Mean KSS scores - every 200 seconds. There were significant effects for between 
conditions, and for time at task 
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Figure 4 Mean standardised theta+alpha (4-11Hz) EEG power - in 1 min epochs (smoothed by 
3 point running average).  There were significant time, and group by time interaction effects, 
whereby OSA patients displayed greater power for the last hour under both sleep conditions. 
 
Figure 5 Mean standardised beta (13-20Hz) EEG power - in 1 min epochs (smoothed by 3 point 
running average). There were significant time, and group by time interaction effects, with OSA 
patients showing more beta power than the control group, beyond the first 30min.   
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Figure 6 Comparisons of KSS with Major Incidents - in 30 min epochs.  Compiled from Figures 
2 and 3. Showing more clearly the disproportionately large increase of incidents for the OSA 
patients after sleep reduction, despite their having similar KSS scores to those of the sleep 
reduced control group (see Results).  
 
 
  
 
